Port Delivery Platform with ranibizumab for treating wet age-related macular degeneration [ID3983]
Awaiting development
Reference number: GID-TA10879
Expected publication date:
As you will be aware the Department for Health and Social Care has asked NICE to carry out a Single Technology Appraisal of the Port Delivery System with ranibizumab for treating wet age-related macular degeneration.
Please note that following on from advice received from the company the timelines for this appraisal are to be confirmed. The appraisal will be rescheduled to align with latest regulatory expectations and an update on the revised timelines will be provided when further information is available.